Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reno Debets

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Cancer Research|February 26, 2025
CXCL10 Secreted by Pericytes Mediates TNFα-Induced Vascular Leakage in Tumors and Enhances Extravasation of Nanoparticle-Based ChemotherapeuticsAnn L B Seynhaeve, Hui Liu, Marjolein I Priester, et al.
Cancers|February 26, 2025
Ultrasonic Aspiration-Acquired Glioblastoma Tissue Preserves Lymphocyte Phenotype and Viability, Supporting Its Use for Immunological StudiesEftychia Stavrakaki, Zineb Belcaid, Rutger K Balvers, et al.
Cancers|April 3, 2021
Germline Variation in <i>PDCD1</i> Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 MonotherapyMirjam de With, Daan P Hurkmans, Esther Oomen-de Hoop, et al.
Cancer Immunology, Immunotherapy : CII|August 17, 2022
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancerMaud Rijnders, Debbie G J Robbrecht, Astrid A M Oostvogels, et al.
Cancer Immunology Research|May 6, 2026
Automated Computational Flow Cytometry Correlates Decreasing Neutrophil-to-Lymphocyte Ratio to Improved Survival in NSCLC After Immune Checkpoint BlockadeKatrien L A Quintelier, Maaike M Hofman, Mandy van Brakel, et al.
British Journal of Cancer|April 27, 2018
Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patientsSander Bins, Edwin A Basak, Samira El Bouazzaoui, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
Correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancerEdwin A Basak, Stijn L W Koolen, Daan P Hurkmans, et al.
Acta Neuropathologica|January 20, 2018
T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expressionDana A M Mustafa, Rute M S M Pedrosa, Marcel Smid, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2022
Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational studyEdwin A Basak, Niels S Vermeer, Karlijn de Joode, et al.
Journal for Immunotherapy of Cancer|June 10, 2019
CD45RA<sup>+</sup>CCR7<sup>-</sup> CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumabAndre Kunert, Edwin A Basak, Daan P Hurkmans, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Cancer Research|February 26, 2025
CXCL10 Secreted by Pericytes Mediates TNFα-Induced Vascular Leakage in Tumors and Enhances Extravasation of Nanoparticle-Based ChemotherapeuticsAnn L B Seynhaeve, Hui Liu, Marjolein I Priester, et al.
Cancers|February 26, 2025
Ultrasonic Aspiration-Acquired Glioblastoma Tissue Preserves Lymphocyte Phenotype and Viability, Supporting Its Use for Immunological StudiesEftychia Stavrakaki, Zineb Belcaid, Rutger K Balvers, et al.
Cancers|April 3, 2021
Germline Variation in <i>PDCD1</i> Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 MonotherapyMirjam de With, Daan P Hurkmans, Esther Oomen-de Hoop, et al.
Cancer Immunology, Immunotherapy : CII|August 17, 2022
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancerMaud Rijnders, Debbie G J Robbrecht, Astrid A M Oostvogels, et al.
Cancer Immunology Research|May 6, 2026
Automated Computational Flow Cytometry Correlates Decreasing Neutrophil-to-Lymphocyte Ratio to Improved Survival in NSCLC After Immune Checkpoint BlockadeKatrien L A Quintelier, Maaike M Hofman, Mandy van Brakel, et al.
British Journal of Cancer|April 27, 2018
Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patientsSander Bins, Edwin A Basak, Samira El Bouazzaoui, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
Correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancerEdwin A Basak, Stijn L W Koolen, Daan P Hurkmans, et al.
Acta Neuropathologica|January 20, 2018
T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expressionDana A M Mustafa, Rute M S M Pedrosa, Marcel Smid, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2022
Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational studyEdwin A Basak, Niels S Vermeer, Karlijn de Joode, et al.
Journal for Immunotherapy of Cancer|June 10, 2019
CD45RA<sup>+</sup>CCR7<sup>-</sup> CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumabAndre Kunert, Edwin A Basak, Daan P Hurkmans, et al.
Pageof 14